Abstract
This paper presents the results of a pilot study to investigate whether the administration of a nocturnal dose of metiamide (the first orally active H2 receptor antagonist) would prevent or delay the relapse of duodenal ulceration after initial ulcer healing. Sixteen patients took part in a double-blind trial to compare metiamide (400 mg) with placebo. Endoscopically confirmed duodenal ulcer relapses occurred in two out of eight on metiamide and six out of eight on placebo. There was a significant prolongation of remission in those in those on the active drug with an apparent reduction in duodenitis.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Blair E. L., Grund E. R., Miller I. T., Redd J. D., Sanders D. J., Thompson M. H., Venables C. W. Metiamide in the Zollinger-Ellison syndrome. Am J Dig Dis. 1975 Dec;20(12):1123–1130. doi: 10.1007/BF01070755. [DOI] [PubMed] [Google Scholar]
- Burland W. L., Duncan W. A., Hesselbo T., Mills J. G., Sharpe P. C., Haggie S. J., Wyllie J. H. Pharmacological evaluation of cimetidine, a new histamine H2-receptor antagonist, in healthy man. Br J Clin Pharmacol. 1975 Dec;2(6):481–486. doi: 10.1111/j.1365-2125.1975.tb00564.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Forrest J. A., Shearman D. J., Spence R., Celestin L. R. Letter: Neutropenia associated with metiamide. Lancet. 1975 Feb 15;1(7903):392–393. doi: 10.1016/s0140-6736(75)91305-7. [DOI] [PubMed] [Google Scholar]
- Haggie S. J., Fermont D. C., Wyllie J. H. Treatment of duodenal ulcer with cimetidine. Lancet. 1976 May 8;1(7967):983–984. doi: 10.1016/s0140-6736(76)91859-6. [DOI] [PubMed] [Google Scholar]
- Henn R. M., Isenberg J. I., Maxwell V., Sturdevant R. A. Inhibition of gastric acid secretion by cimetidine in patients with duodenal ulcer. N Engl J Med. 1975 Aug 21;293(8):371–375. doi: 10.1056/NEJM197508212930802. [DOI] [PubMed] [Google Scholar]
- Milton-Thompson G. J., Williams J. G., Jenkins D. J., Misiewicz J. J. Inhibition of nocturnal acid secretion in duodenal ulcer by one oral dose of metiamide. Lancet. 1974 Apr 20;1(7860):693–694. doi: 10.1016/s0140-6736(74)92901-8. [DOI] [PubMed] [Google Scholar]
- Thompson M. H., Reed J. D., Dale G., Venables C. W. Early clinical experience with metiamide, a histamine H2-receptor antagonist, in patients with duodenal ulcer. Am J Dig Dis. 1975 Dec;20(12):1135–1141. doi: 10.1007/BF01070757. [DOI] [PubMed] [Google Scholar]